1. Phosphopyruvate carboxylase activity rapidly appears in the liver of prematurely delivered rats and development of activity is prevented by injection of actinomycin D just before delivery. 2. The activity is considerably decreased by puromycin and amino acid analogues and thus appears to be due to enzyme synthesis. 3. Newborn or premature animals show a transient intense phase of hypoglycaemia after delivery. 4. When the hypoglycaemic phase is prevented by glucose injection little phosphopyruvate carboxylase activity appears in the liver, but galactose, mannose and fructose, which have no effect on the blood glucose concentration, also repress enzyme development. 5. Lactate, pyruvate and glycerol injections repress the premature development of phosphopyruvate carboxylase. 6. Injections of glucagon, adrenalin and noradrenalin into the rat foetus in utero result in development of phosphopyruvate carboxylase activity. 7. These findings are discussed in relation to the mechanism of initiation of enzyme synthesis in neonatal rat liver.

Amino Acids↗

PubMed1967

Gluconeogenesis from amino acids in neonatal rat liver.

1. The utilization of amino acids for gluconeogenesis by rat liver develops in postnatal life, reaching maximum activity at the fifth day. 2. The activity of aspartate transaminase shows a similar trend in postnatal development and the increased activity appears to be due to the soluble enzyme. 3. The activity of alanine transaminase is low in foetal and postnatal rat liver and increases in activity at about the twentieth day. 4. Aspartate, glutamate and alanine make a major contribution to gluconeogenesis in the postnatal rat liver.

Alanine↗

PubMed1967

Development of gluconeogenesis in neonatal rat liver. Effect of triamcinolone.

1. The normal development of the key enzymes of gluconeogenesis in rat liver, glucose 6-phosphatase, hexose diphosphatase, phosphopyruvate carboxylase and pyruvate carboxylase, was measured during the neonatal period. 2. Glucose 6-phosphatase, hexose diphosphatase and pyruvate carboxylase are all present in the late foetal liver, but all the enzymes show an increase in activity after birth. 3. Phosphopyruvate carboxylase is not present in liver extracts from foetal rats, but activity appears immediately after birth and increases rapidly over the first day and then more slowly to reach its maximum at the fourth postnatal day. 4. The fluorinated synthetic glucocorticoid, triamcinolone, was administered to foetal rats at various gestation times by intraperitoneal injection in utero and the animals were killed at intervals between 4 and 48hr. later. 5. The administration of triamcinolone results in slight depression of glucose 6-phosphatase, and a more significant depression of hexose diphosphatase to about one-half its normal activity in foetal rat liver. 6. Triamcinolone injection is without effect on pyruvate carboxylase activity and does not result in premature appearance of phosphopyruvate carboxylase in foetal rat liver. 7. Pyruvate kinase and aspartate amino-transferase activities in foetal rat liver are both depressed by triamcinolone treatment, whereas phosphofructokinase activity is elevated. 8. Tyrosine amino-transferase activity in foetal rat liver is markedly elevated in animals exposed to triamcinolone for 10hr. or more, but the effect is only observed in animals close to term. 9. The results are discussed in relation to mechanisms involved in the initial synthesis of tissue-specific enzymes in developing tissues, and it is concluded that glucocorticoids do not initiate the synthesis of the gluconeogenic enzymes.

Journal Article↗

PubMed1967

Development of gluconeogenesis in neonatal rat liver. Effect of premature delivery.

1. An assay method for the determination of phosphopyruvate carboxylase activity is described in which improved sensitivity is obtained by separation of the enzyme from interfering pyruvate kinase by zone sedimentation. 2. The molecular weight of rat liver phosphopyruvate carboxylase determined by zone sedimentation is about 68000. 3. Premature delivery of rat foetuses by uterine section results in the rapid appearance of phosphopyruvate carboxylase, but hexose diphosphatase and pyruvate carboxylase, already present in the foetal rat liver, are not significantly affected, and glucose 6-phosphatase activity is only slightly affected. 4. The rate of incorporation of [(14)C]pyruvate into glucose by liver slices is also greatly increased by premature delivery and there is a highly significant linear correlation between this process and the phosphopyruvate carboxylase activity.

Journal Article↗

PubMedDate not supplied

An efficient birdcage resonator at 2.5 MHz using a novel multilayer self-capacitance construction technique.

The birdcage resonator, well appreciated for its high signal-to-noise ratio and its magnetic field uniformity characteristics, operates efficiently in mid- to high-field MRI systems but, unfortunately not for low-field (< 0.4 T) applications. The inherently low inductance of the birdcage architecture is the main obstacle to achieving low-frequency resonance because of the need to use very high-value capacitors for the tuning. Small-case-size, high-value ceramic capacitors are known to have high dissipation factors which when used in the fabrication of RF coils could result in poor efficiency. To overcome this limitation, a novel technique known as multilayer self-capacitance (MLSC) construction has been developed and a prototype 2.5 MHz bird-cage resonator of length 25 cm and diameter 20 cm has been built. The technique involves the modification of the leg sections of the conductors constituting the bird cage into integrated capacitors using very low-loss materials as dielectrics. The observed unloaded Q-factor was 267 using the MLSC construction, and when loaded with a 16-cm-diameter bottle of 0.45% saline, its Q dropped to 246. The RF field uniformity plots have demonstrated that the MLSC technique has no adverse effects on the magnetic field homogeneity of the bird-cage resonator.

Magnetic Resonance Imaging↗